EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer

Rahul Prasad iD, Timothy J Yen, Alfonso Bellacosa iD

Advanced Genetics · 2021

DOI: 10.1002/ggn2.10033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Genetics, 2021. Verfasst von Rahul Prasad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epigenetics and Cancer Biology Programs, Fox Chase Cancer Center Philadelphia Pennsylvania USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Lincoln University, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA methylation is a critical process in the regulation of gene expression with dramatic effects in development and continually expanding roles in oncogenesis. 5‐Methylcytosine was once considered to be an inherited and stably repressive epigenetic mark, which can be only removed by passive dilution during multiple rounds of DNA replication. However, in the past two decades, physiologically controlled DNA demethylation and deamination processes have been identified, thereby revealing the function of cytosine methylation as a highly regulated and complex state—not simply a static, inherited signature or binary on‐off switch. Alongside these fundamental discoveries, clinical studies over the past decade have revealed the dramatic consequences of aberrant DNA demethylation. In this review we discuss DNA demethylation and deamination in the context of 5‐methylcytosine as critical processes for physiological and physiopathological transitions within three states—development, immune maturation, and oncogenic transformation; and we describe the expanding role of DNA demethylating drugs as therapeutic agents in cancer.

Schlagwörter

Stichwörter der Autor:innen

AIDAPOBECDNA deaminationDNA demethylationDNA methylationTDGTET

Autor:innen und Institutionen

  • Cancer Epigenetics and Cancer Biology Programs, Fox Chase Cancer Center Philadelphia Pennsylvania USA.

ORCID-Profile: Rahul Prasad, Alfonso Bellacosa

Förderung

  • NCI NIH HHS
  • Lincoln University
  • U.S. Department of Defense
  • Melanoma Research Alliance
  • The National Cancer Institute

Zitieren

APA

Prasad, R., Yen, T. J., & Bellacosa, A. (2021). Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer. Advanced Genetics. https://doi.org/10.1002/ggn2.10033

Vancouver

Prasad R, Yen TJ, Bellacosa A. Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer. Advanced Genetics. 2021. doi:10.1002/ggn2.10033

BibTeX
@article{Prasad2021,
  author = {Prasad, Rahul and Yen, Timothy J and Bellacosa, Alfonso},
  title = {Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer},
  journal = {Advanced Genetics},
  year = {2021},
  doi = {10.1002/ggn2.10033}
}
Kostenlos starten →